U.S. Supreme Court,
Administrative/Regulatory
Feb. 22, 2023
Supreme Court refuses to consider $302M penalty against J&J
The U.S. Food and Drug Administration banned all trans-vaginal POP mesh devices from the national market in 2019 because of concerns over safety and effectiveness.
The U.S. Supreme Court on Tuesday declined to review a $302 million civil penalty California levied against Johnson & Johnson over false and deceptive marketing of its pelvic mesh products.
“Let this be a strong warning: The California Department of Justice will not hesitate to take action against corporations that violate the law and harm consumers,” Attorney General Rob Bonta said in a statement.
The compa...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$795 for an entire year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In